FAIRBAIRN PLASTIC SURGERY LIMITED
Company number SC682613 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
FAIRBAIRN PLASTIC SURGERY LIMITED - Analysis Report
Company Number: SC682613
Analysis Date: 2025-07-29 20:59 UTC
Risk Rating: LOW
The company demonstrates solid net asset growth, positive working capital, and compliance with filing deadlines. The small scale and micro-entity reporting regime limits detailed financial disclosures but available data suggests sound financial health.Key Concerns:
- Limited Scale and History: Incorporated in late 2020, the company has a relatively short operating history which may limit trend analysis and risk assessment depth.
- Micro-Entity Reporting: Exemption from audit and simplified accounts restrict transparency, potentially obscuring detailed risk factors.
- Single Employee and Director Concentration: Operational dependence on very few key individuals (one director also serving as secretary and only one employee) may pose continuity risks.
- Positive Indicators:
- Improving Financial Position: Net assets increased from £17,668 in 2024 to £41,841 in 2025, with net current assets growing from £10,015 to £33,164, indicating strengthened liquidity.
- Adequate Working Capital: Current assets approximately double current liabilities in the latest year, supporting short-term obligation coverage.
- Regulatory Compliance: No overdue accounts or confirmation statements; filings are up to date, indicating good governance practices.
- Clear Industry Focus: The company is classified under specialists medical practice activities (SIC 86220), suggesting a defined niche potentially benefiting from specialist demand.
- Due Diligence Notes:
- Review Cash Flow Details: Verify underlying cash flows supporting current asset figures to confirm liquidity beyond balance sheet snapshots.
- Understand Revenue and Profitability: Obtain detailed profit and loss data to assess operational sustainability and margin trends.
- Evaluate Dependency on Key Personnel: Assess succession plans or risk mitigation for director/employee reliance.
- Confirm No Undisclosed Liabilities: Given micro-entity exemptions, request supplementary disclosures or management representations on contingent liabilities or off-balance-sheet risks.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.